Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
22.91
+0.67 (3.01%)
At close: Mar 19, 2026, 4:00 PM EDT
22.47
-0.44 (-1.92%)
After-hours: Mar 19, 2026, 7:09 PM EDT

Arcutis Biotherapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
376.07196.5459.613.69-
Revenue Growth (YoY)
91.34%229.73%1517.09%--
Cost of Revenue
36.719.134.990.75-
Gross Profit
339.38177.4154.622.93-
Selling, General & Admin
274.55229.39185.15122.1260.97
Research & Development
77.0576.42110.58182.44145.56
Total Operating Expenses
351.6305.81295.72304.56206.53
Operating Income
-12.23-128.4-241.1-301.63-206.53
Interest Income
8.916.1312.52--
Interest Expense
-12.08-27.17-29.71-15.65-
Other Non-Operating Income (Expense)
0.440.05-0.735.820.17
Total Non-Operating Income (Expense)
-2.74-11-17.93-9.830.17
Pretax Income
-14.97-139.39-259.03-311.46-206.36
Provision for Income Taxes
1.170.653.11--
Net Income
-16.14-140.04-262.14-311.46-206.36
Net Income to Common
-16.14-140.04-262.14-311.46-206.36
Shares Outstanding (Basic)
127121695549
Shares Outstanding (Diluted)
127121695549
Shares Change (YoY)
5.19%74.53%25.94%11.39%38.52%
EPS (Basic)
-0.13-1.16-3.78-5.66-4.18
EPS (Diluted)
-0.13-1.16-3.78-5.66-4.18
Free Cash Flow
-6.31-112.3-247.49-258.05-175.62
Free Cash Flow Per Share
-0.05-0.93-3.57-4.69-3.55
Gross Margin
90.24%90.27%91.63%79.54%-
Operating Margin
-3.25%-65.33%-404.49%-8183.04%-
Profit Margin
-4.29%-71.25%-439.79%-8449.76%-
FCF Margin
-1.68%-57.14%-415.20%-7000.76%-
EBITDA
-7.56-126.44-240.35-300.69-206.08
EBITDA Margin
-2.01%-64.33%-403.23%-8157.70%-
EBIT
-12.23-128.4-241.1-301.63-206.53
EBIT Margin
-3.25%-65.33%-404.49%-8183.04%-
Effective Tax Rate
-7.82%-0.46%-1.20%0.00%0.00%
Updated Feb 25, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q